Latent Cytomegalovirus Reactivation in Patients With Liver Failure: A 10-Year Retrospective Case-Control Study, 2011-2020

Frontiers in Cellular and Infection Microbiology

Yuming Chen¹  Aiping Liu¹  Xuefang Yang²  Zhe Zhou³  Qingluan Yang³  Bingyan Zhang⁴  Jianming Zheng⁴  Lingyun Shao⁵  Wenhong Zhang⁶ 

[1] Clinical Laboratory, Huashan Hospital, Fudan University, Shanghai, China;Department of Infectious Disease, The Second People’s Hospital of Lanzhou, Gansu, China;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China;National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China;National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China;Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China;National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China;Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China;State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China;Key Laboratory of Medical Molecular Virology (MOE/MOH) and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China;

关键词: cytomegalovirus;    reactivation;    liver failure;    glucocorticoids;    mortality;   

DOI  :  10.3389/fcimb.2021.642500

来源: Frontiers

【 授权许可】

CC BY